Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.